TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cells (Q43608830)

25 November 2017

title

TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cells (English)

1 reference

25 November 2017

0 references

1 reference

8

1 reference

25 November 2017

Cristina Bottino

10

0 references

Roberta Castriconi

series ordinal

2

object named as

Roberta Castriconi

1 reference

25 November 2017

9

Alessandro Moretta

1 reference

25 November 2017

3

Alessandra Dondero

1 reference

25 November 2017

7

Lorenzo Moretta

1 reference

25 November 2017

1

Francesca Bellora

1 reference

25 November 2017

Anna Pessino

4

1 reference

25 November 2017

Alessio Nencioni

series ordinal

5

1 reference

25 November 2017

Giovanni Liggieri

series ordinal

6

1 reference

25 November 2017

language of work or name

English

0 references

publication date

6 March 2014

1 reference

European Journal of Immunology

25 November 2017

published in

1 reference

25 November 2017

volume

44

1 reference

25 November 2017

issue

6

1 reference

25 November 2017

page(s)

1814-1822

1 reference

Macrophage plasticity and polarization in tissue repair and remodelling

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

Differential macrophage programming in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

Human NK receptors: from the molecules to the therapy of high risk leukemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

Natural killer cells and solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

NK cells recognize and kill human glioblastoma cells with stem cell-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

Natural killer cells kill human melanoma cells with characteristics of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

Cellular ligands of activating NK receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

Innate or adaptive immunity? The example of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

TGFβ: a sleeping giant awoken by integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

The chemokine system in diverse forms of macrophage activation and polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

The CD16- CD56(bright) NK cell subset is resistant to reactive oxygen species produced by activated granulocytes and has higher antioxidative capacity than the CD16+ CD56(dim) subset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

Long-term proliferation of functional human NK cells, with conversion of CD56(dim) NK cells to a CD56 (bright) phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

Neuroblastoma-derived TGF-β1 modulates the chemokine receptor repertoire of human resting NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

Monocytes and the 38kDa-antigen of mycobacterium tuberculosis modulate natural killer cell activity and their cytolysis directed against ovarian cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

Toll-like receptor activation of human cells by synthetic triacylated lipid A-like molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201344130

21 January 2018

Identifiers

DOI

10.1002/EJI.201344130

1 reference

25 November 2017

1 reference